GB9307754D0 - Diagnostic probes and therapeutic products - Google Patents

Diagnostic probes and therapeutic products

Info

Publication number
GB9307754D0
GB9307754D0 GB939307754A GB9307754A GB9307754D0 GB 9307754 D0 GB9307754 D0 GB 9307754D0 GB 939307754 A GB939307754 A GB 939307754A GB 9307754 A GB9307754 A GB 9307754A GB 9307754 D0 GB9307754 D0 GB 9307754D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic products
diagnostic probes
probes
diagnostic
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939307754A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB939307754A priority Critical patent/GB9307754D0/en
Publication of GB9307754D0 publication Critical patent/GB9307754D0/en
Priority to PCT/EP1994/001183 priority patent/WO1994024308A1/en
Priority to AU66788/94A priority patent/AU6678894A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GB939307754A 1993-04-15 1993-04-15 Diagnostic probes and therapeutic products Pending GB9307754D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB939307754A GB9307754D0 (en) 1993-04-15 1993-04-15 Diagnostic probes and therapeutic products
PCT/EP1994/001183 WO1994024308A1 (en) 1993-04-15 1994-04-15 Diagnostic probes and their use in detecting human chromosomal abnormalities
AU66788/94A AU6678894A (en) 1993-04-15 1994-04-15 Diagnostic probes and their use in detecting human chromosomal abnormalities

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939307754A GB9307754D0 (en) 1993-04-15 1993-04-15 Diagnostic probes and therapeutic products

Publications (1)

Publication Number Publication Date
GB9307754D0 true GB9307754D0 (en) 1993-06-02

Family

ID=10733850

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939307754A Pending GB9307754D0 (en) 1993-04-15 1993-04-15 Diagnostic probes and therapeutic products

Country Status (3)

Country Link
AU (1) AU6678894A (en)
GB (1) GB9307754D0 (en)
WO (1) WO1994024308A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990067011A (en) * 1995-10-23 1999-08-16 임페리얼 캔서 리서치 테크놀로지 리미티드 Susceptibility Diagnosis for Cancer and Its Treatment Methods
US6287854B1 (en) 1996-10-22 2001-09-11 Imperial Cancer Research Technology Limited Diagnosis of susceptibility to cancer and treatment thereof
EP0878552A1 (en) * 1997-05-13 1998-11-18 Erasmus Universiteit Rotterdam Molecular detection of chromosome aberrations
CA2367906A1 (en) * 1999-03-15 2000-09-21 Thomas Jefferson University Tcl-1b gene and protein and related methods and compositions
AU2008283997B2 (en) 2007-08-03 2014-04-10 The Ohio State University Research Foundation Ultraconserved regions encoding ncRNAs
US8911998B2 (en) 2007-10-26 2014-12-16 The Ohio State University Methods for identifying fragile histidine triad (FHIT) interaction and uses thereof
CN102149827B (en) 2008-06-11 2014-08-20 由卫生与公众服务部代表的美利坚合众国政府 Use of MiR-26 family as a predictive marker of hepatocellular carcinoma and responsiveness to therapy
AU2010321555B2 (en) 2009-11-23 2015-10-15 The Ohio State University Materials and methods useful for affecting tumor cell growth, migration and invasion
CA2816603A1 (en) 2010-11-12 2012-05-18 The Ohio State University Research Foundation Materials and methods related to microrna-21, mismatch repair, and colorectal cancer
CN103313706A (en) 2010-11-15 2013-09-18 俄亥俄州立大学研究基金会 Controlled release mucoadhesive systems
WO2013056217A1 (en) 2011-10-14 2013-04-18 The Ohio State University Methods and materials related to ovarian cancer
CN104619353A (en) 2011-12-13 2015-05-13 俄亥俄州国家创新基金会 Methods and compositions related to miR-21 and miR-29a, exosome inhibition, and cancer metastasis
JP2015511121A (en) 2012-01-20 2015-04-16 ジ・オハイオ・ステート・ユニバーシティ Breast cancer biomarker signature for invasiveness and prognosis
US20160296352A1 (en) 2015-04-13 2016-10-13 Cook Medical Technologies Llc Axial lock and release stent deployment system

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2063409A1 (en) * 1989-07-03 1991-01-04 Carlo M. Croce Tcl-5 gene rearrangement involved in t-cell leukemia and melanoma

Also Published As

Publication number Publication date
AU6678894A (en) 1994-11-08
WO1994024308A1 (en) 1994-10-27

Similar Documents

Publication Publication Date Title
GB2277826B (en) Surgical and/or clinical apparatus
GB2283678B (en) Cryosurgical catheter probe
GB9415125D0 (en) Surgical product and its use
GB2276551B (en) Electrosurgery monitor and apparatus
GB2263974B (en) Ultrasound imaging and catheters for use therein
HK1013946A1 (en) Temperature-sensitive medical apparatus
IL109545A0 (en) Medical probe with stylets
AP9400630A0 (en) Diagnostic device and method
GB9307754D0 (en) Diagnostic probes and therapeutic products
IL106037A0 (en) Therapeutic and diagnostic methods based on neurotrophin-4-expression
GB9514816D0 (en) Substances and their medical use
GB2279120B (en) Slidable assemblies and probe elements
GB9120768D0 (en) Diagnostic and prognastic materials and methods
ZA976547B (en) Lipid-binding proteins and their therapeutic and diagnostic use
GB9616504D0 (en) Therapeutic product and its use
GB9317185D0 (en) Diagnostic method and therapy
GB9312182D0 (en) Pain location and stimulation probe
GB9201191D0 (en) Diagnostic and therapeutic compounds
ZA934284B (en) Therapeutic and diagnostic methods based on neurotrophin-4 expression
ZA923716B (en) Therapeutic and diagnostic methods based on neurotrophin-4 expression
GB9325494D0 (en) Ultrasound probes
GB9101435D0 (en) Therapeutic and diagnostic compounds
GB9101436D0 (en) Diagnostic and therapeutic compounds
GB9107172D0 (en) Therapeutic and diagnostic compounds
GB8927669D0 (en) Diagnostic agents and methods